Back to Search Start Over

Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.

Authors :
Qu, Ning
Zhang, Ling
Wu, Wei-li
Ji, Qing-hai
Lu, Zhong-wu
Zhu, Yong-xue
Lin, Dao-zhe
Source :
Tumor Biology (Springer Science & Business Media B.V.); Jul2016, Vol. 37 Issue 7, p8783-8789, 7p
Publication Year :
2016

Abstract

Papillary thyroid cancer (PTC) often presents as multifocal tumor;, however, whether multifocality is associated with poor prognosis remains controversial. The aims of this retrospective study were to identify the characteristics of PTC with multifocal tumors and evaluate the association between the location and prognosis. We reviewed the medical records of 496 patients who underwent total thyroidectomy for PTC. Patients were classified as three groups: N1 (solitary tumor), N2 (2 or more foci within unilateral lobe of thyroid), and N3 (bilateral tumors, at least one tumor focus for each lobe of thyroid). We analyzed the differences of clinicopathologic features and clinical outcomes among the three groups. Cox regression model was used to assess the relation between the different locations of multifocal tumors and prognosis. Although the differences of clinicopathologic features such as the size of tumor, extrathyroidal extension, and cervical lymph node metastasis were not significant among the three groups, the bilateral-multifocality was proved to be an independent risk factor for neck recurrence (hazard ratio (HR) = 4.052, 95 % confidence interval (CI) 2.070-7.933), distant metastasis (HR = 3.860, 95 % CI 1.507-9.884), and cancer death (HR = 7.252, 95 % 2.189-24.025). In addition, extrathyroidal extension (HR = 2.291, 95 % CI 1.185-4.427) and older age >45 years (HR = 6.721, 95 % CI 2.300-19.637) were also significant predictors for neck recurrence and cancer death, respectively. Therefore, bilateral-multifocality as an indicator for more extensive tumor location could be used to assess the risk of recurrence and mortality in PTC. Given the poor prognosis associated with bilateral-multifocality and other risk factors, aggressive therapy and intensive follow-up were recommended for PTC patients with them. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10104283
Volume :
37
Issue :
7
Database :
Complementary Index
Journal :
Tumor Biology (Springer Science & Business Media B.V.)
Publication Type :
Academic Journal
Accession number :
117522466
Full Text :
https://doi.org/10.1007/s13277-015-4533-5